retinal dystrophies
Showing 1 - 11 of 11
Objective Perimetry Using Chromatic Multifocal Pupillometer
Recruiting
- Retinal Dystrophies
- +2 more
-
Tel HaShomer, IsraelSheba Medical Center
Jan 15, 2023
EyeConic: Qualification for Cone-Optogenetics
Recruiting
- Retinal Dystrophies
- OCT
-
San Francisco, California
- +8 more
Nov 1, 2022
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Recruiting
- Retinitis Pigmentosa
- +4 more
-
San Francisco, California
- +4 more
Oct 5, 2022
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Qualification for Cone-Optogenetics
Recruiting
- Retinal Dystrophies
- OCT
-
San Francisco, California
- +8 more
Jan 19, 2022
Retinal Disease, Retinal Degeneration, Retinal Dystrophies Trial in Oxford (Long-wavelength autofluorescence imaging)
Recruiting
- Retinal Disease
- +2 more
- Long-wavelength autofluorescence imaging
-
Oxford, United KingdomOxford Eye Hospital
Jul 20, 2021
Retinal Dystrophies Trial in Montpellier (Skin biopsy)
Recruiting
- Retinal Dystrophies
- Skin biopsy
-
Montpellier, Occitanie, FranceCNMR Maolya, Genetic Sensory Diseases
Mar 30, 2020
Retinal Dystrophies, Healthy Trial in Ann Arbor (Head-Mounted Display)
Completed
- Retinal Dystrophies
- Healthy
- Head-Mounted Display
-
Ann Arbor, MichiganKellogg Eye Center
Sep 20, 2019
Retinal Dystrophies Trial (Intravitreal ranibizumab (IVR) injection, Carbonic Anhydrase Inhibitor (CAI) therapy)
Completed
- Retinal Dystrophies
- Intravitreal ranibizumab (IVR) injection
- Carbonic Anhydrase Inhibitor (CAI) therapy
- (no location specified)
Sep 20, 2019
Retinal Imaging by Adaptive Optics in Healthy Eyes and During
Unknown status
- Retinal Dystrophies
- +5 more
-
Paris, FranceClinical Investigation Center 503
Feb 23, 2016